Loading...
In a 2011 examination of preclinical and clinical data (JW Psychiatry May 2 2011), researchers suggested that nonsteroidal anti-inflammatory drugs (NSAIDs) interfere with the antidepressant efficacy of selective serotonin reuptake inhibitors (SSRIs) through a specific interaction with the serotonin receptor. To further examine this interaction, the current researchers analyzed the effect of NSAIDs on the antidepressant efficacy of escitalopram (10–30 mg/day) and nortriptyline (50–200 mg/day) in 811 patients with major depression who were enrolled in a partially randomized clinical and pharmacogenetic study that had received some industry support.
Seventy-eight patients (10%) were taking NSAIDs, and 59 (7%) were taking analgesics. Use of anal…